menu
    • menu
    [{"orgOrder":0,"company":"INMUNOVA","sponsor":"Exeltis | Chemo Research | Linical | KLIXAR","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"ARGENTINA","productType":"Antibody","year":"2024","type":"Inapplicable","leadProduct":"INM004","moa":"Shiga Toxin","graph1":"Hematology","graph2":"Phase III","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ Exeltis | Chemo Research | Linical | KLIXAR","highestDevelopmentStatusID":"10","companyTruncated":"INMUNOVA \/ Exeltis | Chemo Research | Linical | KLIXAR"},{"orgOrder":0,"company":"INMUNOVA","sponsor":"KLIXAR | Linical | PHV LATAM","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"ARGENTINA","productType":"Antibody","year":"2022","type":"Inapplicable","leadProduct":"INM004","moa":"Shiga Toxin","graph1":"Gastroenterology","graph2":"Phase II","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ KLIXAR | Linical | PHV LATAM","highestDevelopmentStatusID":"8","companyTruncated":"INMUNOVA \/ KLIXAR | Linical | PHV LATAM"},{"orgOrder":0,"company":"INMUNOVA","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"ARGENTINA","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"INM005","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"INMUNOVA","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"INMUNOVA \/ Inapplicable","highestDevelopmentStatusID":"9","companyTruncated":"INMUNOVA \/ Inapplicable"}]

    Find Clinical Drug Pipeline Developments & Deals by INMUNOVA

    Menu

    INMUNOVA

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : INM004

                            Therapeutic Area : Hematology

                            Study Phase : Phase III

                            Sponsor : Exeltis | Chemo Research | Linical | KLIXAR

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of INM004 in Children With STEC-HUS

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Antibody

                            Upfront Cash : Inapplicable

                            April 29, 2024

                            Lead Product(s) : INM004

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase III

                            Sponsor : Exeltis | Chemo Research | Linical | KLIXAR

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : INM004

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase II

                            Sponsor : KLIXAR | Linical | PHV LATAM

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Antibody

                            Upfront Cash : Inapplicable

                            October 06, 2022

                            Lead Product(s) : INM004

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase II

                            Sponsor : KLIXAR | Linical | PHV LATAM

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : INM005

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II/ Phase III

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            July 31, 2020

                            Lead Product(s) : INM005

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II/ Phase III

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : INM004

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II/ Phase III

                            Sponsor : Exeltis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Antibody

                            Upfront Cash : Inapplicable

                            October 18, 2019

                            Lead Product(s) : INM004

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II/ Phase III

                            Sponsor : Exeltis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed

                            INMUNOVA

                            Argentina arrow
                            Formnext Forum
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : INM004

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Hospital Italiano de Buenos Aires

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Antibody

                            Upfront Cash : Inapplicable

                            January 02, 2018

                            Lead Product(s) : INM004

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Hospital Italiano de Buenos Aires

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth